Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics Inc. (DMAC) EBT (2018 - 2019)

DiaMedica Therapeutics (DMAC) has 2 years of EBT data on record, last reported at -$2.5 million in Q4 2019.

  • For Q4 2019, EBT fell 26.62% year-over-year to -$2.5 million; the TTM value through Dec 2019 reached -$10.6 million, down 87.8%, while the annual FY2024 figure was -$24.4 million, 26.25% down from the prior year.
  • EBT reached -$2.5 million in Q4 2019 per DMAC's latest filing, down from -$2.4 million in the prior quarter.
  • Across five years, EBT topped out at -$649000.0 in Q1 2018 and bottomed at -$3.2 million in Q1 2019.